|
مقاله
|
Abstract
|
|
|
|
Title:
|
Treatment outcome of acquired retinal pigment epithelial tumors with Rhuthenium-106 plaque radiotherapy; Experience on three cases
|
|
Author(s):
|
Masood Naseripour, Parya Abdolalizadeh, Ahad Sedaghat, Ehsan Azizi
|
|
Presentation Type:
|
Oral
|
|
Subject:
|
Posterior Segment
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Parya Abdolalizadeh
|
|
Affiliation :(optional)
|
Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences
|
|
E mail:
|
paryaabdolalizadeh@gmail.com
|
|
Phone:
|
|
|
Mobile:
|
09141496696
|
|
|
|
|
Purpose:
|
To report the clinical outcome of rhuthenium-106 plaque radiotherapy in acquired RPE tumors.
|
|
Methods:
|
The clinical finding, management and outcomes of three cases with acquired RPE tumor referred to ocular oncologic clinic at a university based hospital (Rassoul Akram Hospital, Tehran, Iran) or senior author’s (MN) private clinic from August 2013 to May 2017 were evaluated. Plaque radiotherapy with rhuthenium-106 was considered in the management of all three cases.
|
|
Results:
|
The age of patients were 31, 32 and, 44 years old. Two patients were female and the other one was male. The follow-up times were 7, 10 and 50 months. The tumor was unilateral and hyperpigmented in all cases, located at juxta-papillary in one patient and on peripheral part of retina in the others. Vitreous hemorrhage and peripheral exudation was obvious in two patients. Macular edema, epiretinal membrane and retinal feeder vessels were also detected in the examination. All patients underwent plaque radiotherapy with rhuthenium-106 as first or second step of management. The tumor has been stable until last follow-up in all patients with globe preservation and acceptable visual acuity
|
|
Conclusion:
|
Rhuthenium-106 plaque radiotherapy might be a conservative therapy in the management of acquired RPE tumors that prevents early enucleation.
|
|
Attachment:
|
|
|
|